VA Boise, Idaho Medical Center Lab - New Blood Reagents Requirement

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

260-NETWORK CONTRACT OFFICE 20 (36C260)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C26027Q0109

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

Q301

Additional Details
Set Aside

NONE

Place of Performance

Boise, Idaho, UNITED STATES

SourceSAM
Documents4
The Department of Veterans Affairs (VA), through its Network Contract Office 20, has issued a solicitation for the supply of red blood cell reagents to support the Transfusion Services Department at the Boise, Idaho VA Medical Center (VAMC). This procurement is critical to ensuring the safe and effective matching of donated blood products to recipients requiring life-saving treatments across major hospital departments, including Emergency, Surgery, Oncology, and Medical Units. The Transfusion Medicine Department is a site-specific service essential to the operation of each VAMC, and its uninterrupted function is vital for patient care. The scope of this requirement encompasses the provision of red blood cell reagents, quality control check cells, and antibody identification panel cells. These reagents must adhere to stringent quality control and compliance standards, meeting the current regulations and standards set forth by the Food and Drug Administration (FDA), the College of American Pathologists (CAP), the Joint Commission (TJC), and the American Association of Blood Banks (AABB). The vendor is expected to maintain meticulous records of lot numbers and expiration dates for each reagent supplied, given the rapid expiration of cellular materials. To ensure continuous availability, the vendor must proactively supply new lot numbers shortly before the previous ones expire, thereby preventing any disruption in blood product matching operations. The contract is structured as a five-year agreement, with a base year period of performance from December 1, 2026, to November 30, 2027, and four additional option years subject to the Government’s discretion and needs. The procurement falls under NAICS Code 325413 (In-Vitro Diagnostic Substance Manufacturing), with Product Service Code Q301. There are no set-aside requirements for this solicitation, making it open to all qualified vendors. The place of performance is Boise, Idaho, and the contracting entity is the 260-Network Contract Office 20, a federal office within the Department of Veterans Affairs. Interested parties should direct inquiries and responses to Andrew O'Neal at andrew.o'[email protected]. The solicitation is active, with a response deadline of November 19, 2026. Additional details and attachments are available via the SAM.gov opportunity link: https://sam.gov/opp/49ba0cfa8666413092be7c229462c0b4/view. Contractors considering this opportunity should ensure their products and processes align with the specified regulatory standards, possess robust inventory management capabilities for lot tracking and expiration monitoring, and demonstrate reliability in supporting the critical needs of hospital transfusion services over the contract lifecycle.